Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 21 most recent Form 4 transactions.
| MEXER◷◆ |
| 18,606 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| May 7 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 18,606 | $24.12 | $448.8K | -97.8% | Open the original filing on SEC.gov |
| May 7 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 18,606 | $9.88 | $183.8K | +4,399% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | MEXER◷◆ | 47,000 | — | — | — | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 8,900 | $22.57 | $200.9K | -95.5% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 9,219 | $21.37 | $197K | -49.7% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 2,700 | $20.76 | $56.1K | -12.7% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 12,347 | $19.28 | $238.1K | -36.8% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 13,834 | $18.55 | $256.7K | -29.2% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 47,000 | $8.04 | $377.9K | +11,111% | Open the original filing on SEC.gov |
| Apr 30 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 8,457 | $13.23 | $111.9K | -95.2% | Open the original filing on SEC.gov |
| Apr 29 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 8,458 | $13.09 | $110.7K | -48.8% | Open the original filing on SEC.gov |
| Apr 2 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 1,780 | $17.57 | $31.3K | -9.3% | Open the original filing on SEC.gov |
| Apr 2 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 6,200 | $17.02 | $105.6K | -24.5% | Open the original filing on SEC.gov |
| Apr 1 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 7,479 | $16.83 | $125.8K | -22.8% | Open the original filing on SEC.gov |
| Apr 1 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 500 | $15.86 | $7.9K | -1.5% | Open the original filing on SEC.gov |
| Mar 28 | AVTX | Avalo Therapeutics, Inc. | MEXER◆ | 24,200 | — | — | — | Open the original filing on SEC.gov |
| Mar 28 | AVTX | Avalo Therapeutics, Inc. | FTAX | 8,241 | $13.89 | $114.5K | -19.8% | Open the original filing on SEC.gov |
| Mar 28 | AVTX | Avalo Therapeutics, Inc. | MEXER | 24,200 | — | — | +139.6% | Open the original filing on SEC.gov |